Key result
Donepezil alleviated visual task performance deficits and increased posterior cortical activation in young adults vulnerable to 24 hours of sleep deprivation.
Why the study?
Does donepezil improve behavioral performance and task-related brain activation in sleep-deprived healthy young adults?
RCT (n=28)
Double-blind
Does donepezil improve behavioral performance and task-related brain activation in sleep-deprived healthy young adults?
Cholinergic augmentation with donepezil can alleviate visual attention and processing deficits in individuals vulnerable to sleep deprivation, though it may have neutral or negative effects on those resistant to it.
May support donepezil for visual deficits in sleep-vulnerable young adults; extends cholinergic augmentation evidence to acute sleep deprivation.
Using 24 h of total sleep deprivation to perturb normal cognitive function, we conducted a double-blind, placebo-controlled crossover study to evaluate the effect of the acetylcholinesterase inhibitor, donepezil, on behavioral performance and task-related brain activation in 28 healthy, young, adult volunteers. The behavioral tasks involved the parametric manipulation of visual short-term memory load and perceptual load in separate experiments indirectly evaluating attention. Sleep deprivation significantly reduced posterior cortical activation (intraparietal sulcus and extrastriate cortex) at all levels of visual memory as well as perceptual load. Donepezil modulated an individual's performance in both tasks in accordance to whether accuracy declined after sleep deprivation without treatment. Critically, there were significant correlations between donepezil-induced increases in neural activation in the posterior cortical areas and improvement in accuracy. Reduced visual short-term memory after sleep deprivation may thus originate from a decline in visual attention and/or visual processing. Cholinergic augmentation can alleviate these deficits in individuals vulnerable to the effects of sleep deprivation, but it may have neutral or negative effects on those resistant to sleep deprivation.
No takes yet. Share an insight, caveat, or question.
Chuah et al. (2008) conducted an RCT in Sleep deprivation (n=28). Donepezil vs. Placebo was evaluated on Behavioral performance and task-related brain activation. Donepezil alleviated visual task performance deficits and increased posterior cortical activation in young adults vulnerable to 24 hours of sleep deprivation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Journal of Neuroscience